Houston Wire & Cable Co (HWCC) Jumps 7.33% on January 26

Equities Staff |

Houston Wire & Cable Co (HWCC) was among the biggest gainers on the Russell 2000 for Tuesday January 26 as the stock popped 7.33% to $5.42, representing a gain of $0.37 per share. Some 52,539 shares traded hands on 292 trades, compared with an average daily volume of 94,148 shares out of a total float of 16.76 million. The stock opened at $5.09 and traded with an intraday range of $5.43 to $5.05.

After today's gains, Houston Wire & Cable Co reached a market cap of $90.86 million. Houston Wire & Cable Co has had a trading range between $11.56 and $4.79 over the last year, and it had a 50-day SMA of $5.47 and a 200-day SMA of $7.47.

The stock has a P/E Ratio of 14.9.

Houston Wire & Cable Co provides specialty wires and cable and related services to the U.S. electrical distribution market.

Houston Wire & Cable Co is based out of Houston, TX and has some 360 employees. Its CEO is James L. Pokluda.

For a complete fundamental analysis analysis of Houston Wire & Cable Co, check out Equities.com’s Stock Valuation Analysis report for HWCC. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Airbnb

Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…

Pinterest

Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…